News

The funding will be used for the pre-clinical development of a novel vaccine to prevent meningitis B infection in children. Action Medical Research senior research evaluation manager Dr

The initial aim of the collaboration is to pursue a comprehensive and systematic approach to identify and develop physiological mechanisms and targets that regulate beta cell replication. Evotec

The open-labeled trial (GRASPALL-GRAALL SA2 2008) introduced GRASPA in a first-line treatment for Acute Lymphoblastic Leukemia (ALL) in patients older than 55 years. The clinical end point combines

Tris Pharma said if the drug will be approved by the FDA its extended release suspension will offer an alternative to the currently available immediate release formulations. The

TARIS is a specialty pharmaceutical company engaged in developing a pipeline of new therapeutics designed to leverage common, minimally invasive urologic procedures to deliver and maintain drug directly

The study is designed to determine the safety, efficacy, pharmacokinetics, pharmacodynamics of single doses of SAN-300. In the trial, the company is evaluating around 60 patients including healthy

Innoslim is a clinically validated natural calorie-reducing and metabolism-boosting nutraceutical derived from the Notoginseng and Astragalus plants. The dietary ingredient has been shown in cell and animal studies

The tie up allows Crucell to use Pepscan’s proprietary technology to develop new vaccines targeting infectious diseases. As per the terms of the agreement, Crucell is responsible to

NanoCrystal technology was developed by EDT through Elan Pharma International Limited and other Elan affiliates. EDT, the drug delivery unit of Elan Corporation, said the NanoCrystal technology enables